3.66 M
About BIOCELTIX
Sector
CEO
Lukasz Piotr Bzdzion
Headquarters
Wroclaw
Website
Founded
2018
ISIN
PLBCLTX00019
FIGI
BBG013DQ9F61
Bioceltix SA engages in the research and development in the area of veterinary medicine. It develops stem cell therapy for animal use. The company was founded on August 13, 2018 and is headquartered in Wroclaw, Poland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BCX is 70.9 PLN — it has decreased by 0.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange BIOCELTIX stocks are traded under the ticker BCX.
BCX stock is 0.71% volatile and has beta coefficient of 0.21. Check out the list of the most volatile stocks — is BIOCELTIX there?
Yes, you can track BIOCELTIX financials in yearly and quarterly reports right on TradingView.
BCX stock has fallen by 1.12% compared to the previous week, the month change is a 15.39% fall, over the last year BIOCELTIX has showed a 29.38% increase.
BCX net income for the last quarter is −3.52 M PLN, while the quarter before that showed −3.77 M PLN of net income which accounts for 6.56% change. Track more BIOCELTIX financial stats to get the full picture.
Today BIOCELTIX has the market capitalization of 293.19 M, it has decreased by 11.56% over the last week.
No, BCX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BCX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCELTIX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCELTIX technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCELTIX stock shows the neutral signal. See more of BIOCELTIX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.